_____ is an erythroid maturation agent, recently approved by the FDA for the treatment of transfusion-dependent thalassemia.
Type I HIT is _____ common than Type II HIT
_____ is an oral HIF prolyl hydroxylase inhibitor, used to treat anemia in CKD.
What is a recently approved non-salt-based iron preparation with fewer gastrointestinal side effects given orally?_____
Procoagulant drugs such as _____ can be used in hemoptysis if there is an abnormal coagulation profile
_____ is the drug of choice in cerebral venous thrombosis.
Dicoumarol inhibits the action of vitamin K by _____ inhibition.
_____ prophylaxis is recommended for prophylaxis in pregnant women who are on antiepileptic drugs having enzyme-inducing properties.
Which GpIIb/IIIa inhibitors are contraindicated in renal failure?_____
Which tPA (fibrinolytic) has the lowest incidence of intracranial hemorrhage?_____
Hematopoietic Growth Factors
Flashcards
Iron Preparations and Management of Iron Deficiency
Flashcards
Vitamin B12 and Folic Acid
Flashcards
Anticoagulants: Heparins and Direct Inhibitors
Flashcards
Oral Anticoagulants
Flashcards
Antiplatelet Drugs
Flashcards
Thrombolytic Agents
Flashcards
Hemostatic Drugs
Flashcards
Plasma Expanders
Flashcards
Blood Transfusion and Alternatives
Flashcards
Get full access to all flashcards, spaced repetition, and progress tracking.
Start For Free